Skip to content

Clinical trials

Completed Observational Myeloproliferative Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myeloproliferative Disorders Phase: Observational Status: Completed Clear all

50 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20063
20077
20083
20094
20101
20122
20131
20142
20152
20162
20173
20181
20196
20204
20212
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed50

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS3
University Hospital, Bordeaux3
City of Hope Medical Center2
Icahn School of Medicine at Mount Sinai2
Incyte Corporation2
Medical University of Graz2
SWOG Cancer Research Network2
University Hospital, Brest2
AUSL Romagna Rimini1
Arizona State University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myeloproliferative Disorders50
Myelodysplastic Syndromes17
Multiple Myeloma14
Primary Myelofibrosis13
Lymphoma11
Polycythemia Vera11
Thrombocythemia, Essential11
Leukemia10
Leukemia, Myeloid, Acute10
Leukemia, Lymphocytic, Chronic, B-Cell9

Trials

Showing 1 to 25 of 50. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.